Kenvue fights back against Tylenol safety concerns as its stock tumbles

Kenvue rushed to the defense of Tylenol, but the stock still suffered a record selloff on news that RFK Jr. will release a report linking the use of acetaminophen during pregnancy to autism.

Source: MarketWatch

Earnings

‘This is to gain control of the most powerful agency in government’: A look at Treasury Secretary Bessent’s essay against the Fed

05. September 2025

Earnings

Forget Salesforce and Adobe. This under-the-radar software stock is winning in the AI era.

05. September 2025

Earnings

Jobs report shows meager 22,000 gain in August and unemployment hits nearly 4-year high. Weak hiring tees up Fed rate cut.

05. September 2025

Earnings

Yieldstreet tell investors in $89 million worth of marine loans to expect losses

05. September 2025

Kenvue fights back against Tylenol safety concerns as its stock tumbles

Related Articles

‘This is to gain control of the most powerful agency in government’: A look at Treasury Secretary Bessent’s essay against the Fed

Forget Salesforce and Adobe. This under-the-radar software stock is winning in the AI era.

Jobs report shows meager 22,000 gain in August and unemployment hits nearly 4-year high. Weak hiring tees up Fed rate cut.

Yieldstreet tell investors in $89 million worth of marine loans to expect losses